• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素-(1-7):最新进展

Angiotensin-(1-7): an update.

作者信息

Santos R A, Campagnole-Santos M J, Andrade S P

机构信息

Departamento de Fisiologia e Biofísica, Av. Antonio Carlos, 6627 - Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901, Belo Horizonte, MG Brazil.

出版信息

Regul Pept. 2000 Jul 28;91(1-3):45-62. doi: 10.1016/s0167-0115(00)00138-5.

DOI:10.1016/s0167-0115(00)00138-5
PMID:10967201
Abstract

The renin-angiotensin system is a major physiological regulator of arterial pressure and hydro-electrolyte balance. Evidence has now been accumulated that in addition to angiotensin (Ang) II other Ang peptides [Ang III, Ang IV and Ang-(1-7)], formed in the limited proteolysis processing of angiotensinogen, are importantly involved in mediating several actions of the RAS. In this article we will review our knowledge of the biological actions of Ang-(1-7) with focus on the puzzling aspects of the mediation of its effects and the interaction Ang-(1-7)-kinins. In addition, we will attempt to summarize the evidence that Ang-(1-7) takes an important part of the mechanisms aimed to counteract the vasoconstrictor and proliferative effects of Ang II.

摘要

肾素-血管紧张素系统是动脉血压和水电解质平衡的主要生理调节因子。现已积累的证据表明,除了血管紧张素(Ang)II外,在血管紧张素原的有限蛋白水解过程中形成的其他Ang肽[Ang III、Ang IV和Ang-(1-7)],在介导肾素-血管紧张素系统的多种作用中也起着重要作用。在本文中,我们将回顾我们对Ang-(1-7)生物学作用的认识,重点关注其作用介导的令人困惑的方面以及Ang-(1-7)与激肽的相互作用。此外,我们将试图总结证据,表明Ang-(1-7)在旨在抵消Ang II的血管收缩和增殖作用的机制中起重要作用。

相似文献

1
Angiotensin-(1-7): an update.血管紧张素-(1-7):最新进展
Regul Pept. 2000 Jul 28;91(1-3):45-62. doi: 10.1016/s0167-0115(00)00138-5.
2
Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.绘制组织中的血管紧张素转换酶以及血管紧张素AT1、AT2和AT4受体。
J Hypertens. 1998 Dec;16(12 Pt 2):2027-37. doi: 10.1097/00004872-199816121-00026.
3
Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels.
Hypertension. 2001 Sep;38(3 Pt 2):660-4. doi: 10.1161/01.hyp.38.3.660.
4
Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.体育锻炼与肾素血管紧张素系统的ACE2-血管紧张素-(1-7)-Mas受体轴
Protein Pept Lett. 2017 Nov 17;24(9):809-816. doi: 10.2174/0929866524666170728151401.
5
The intrarenal renin-angiotensin system in hypertension.高血压中的肾内肾素-血管紧张素系统
Adv Chronic Kidney Dis. 2015 May;22(3):204-10. doi: 10.1053/j.ackd.2014.11.004.
6
New insights into actions of the renin-angiotensin system in the kidney: concentrating on the Ang II receptors and the newly described Ang-(1-7) and its receptor.肾素 - 血管紧张素系统在肾脏中作用的新见解:聚焦于血管紧张素II受体以及新描述的血管紧张素 -(1 - 7)及其受体。
Semin Nephrol. 2001 Nov;21(6):535-43. doi: 10.1053/snep.2001.26792.
7
Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.通过血管紧张素转换酶抑制和AT1受体拮抗作用对肾小球血管紧张素II受体的调节。
Regul Pept. 1997 Jan 29;68(2):111-7. doi: 10.1016/s0167-0115(96)02112-x.
8
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.肾素-血管紧张素系统阻断对肾脏血管紧张素-(1-7)生成酶及受体的影响。
Kidney Int. 2005 Nov;68(5):2189-96. doi: 10.1111/j.1523-1755.2005.00675.x.
9
Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.ACE - 血管紧张素II - AT1轴和ACE2 - 血管紧张素 -(1 - 7)- Mas轴对活性氧介导的血管功能调控的反调节作用:控制血管并发症的药理学方法展望
Vasa. 2014 Nov;43(6):404-14. doi: 10.1024/0301-1526/a000387.
10
Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats.血管紧张素II内化对大鼠肾内血管紧张素II水平的作用。
Am J Physiol Renal Physiol. 2002 Nov;283(5):F1003-10. doi: 10.1152/ajprenal.00322.2001.

引用本文的文献

1
Therapeutic Efficacy of HPβ-CD-Angiotensin-(1-7) Oral Formulation in Muscle Injury Recovery in Rat.
J Cell Mol Med. 2025 Sep;29(18):e70851. doi: 10.1111/jcmm.70851.
2
Angiotensin‑converting enzyme 2 expression in human tumors: Implications for prognosis and therapy (Review).血管紧张素转换酶2在人类肿瘤中的表达:对预后和治疗的影响(综述)
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8934. Epub 2025 Jun 27.
3
Novel Antihypertensive Medications to Target the Renin-Angiotensin System: Mechanisms and Research.靶向肾素-血管紧张素系统的新型抗高血压药物:作用机制与研究
Rev Cardiovasc Med. 2025 Apr 21;26(4):27963. doi: 10.31083/RCM27963. eCollection 2025 Apr.
4
Timing matters in the use of renin-angiotensin system modulators and COVID-related cognitive and cerebrovascular dysfunction.肾素-血管紧张素系统调节剂的使用时机与 COVID 相关认知和脑血管功能障碍有关。
PLoS One. 2024 Jul 29;19(7):e0304135. doi: 10.1371/journal.pone.0304135. eCollection 2024.
5
Modulatory Effects of the Kuwanon-Rich Fraction from Mulberry Root Bark on the Renin-Angiotensin System.桑白皮中富含库瓦诺酮的组分对肾素-血管紧张素系统的调节作用。
Foods. 2024 May 16;13(10):1547. doi: 10.3390/foods13101547.
6
Alternative Renin-Angiotensin System.替代肾素-血管紧张素系统。
Hypertension. 2024 May;81(5):964-976. doi: 10.1161/HYPERTENSIONAHA.123.21364. Epub 2024 Feb 16.
7
Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.Mas 受体:缺血性心血管疾病治疗的潜在策略。
Cell Cycle. 2023 Jul;22(13):1654-1674. doi: 10.1080/15384101.2023.2228089. Epub 2023 Jun 26.
8
Edema formation in congestive heart failure and the underlying mechanisms.充血性心力衰竭中的水肿形成及其潜在机制。
Front Cardiovasc Med. 2022 Sep 27;9:933215. doi: 10.3389/fcvm.2022.933215. eCollection 2022.
9
The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.血管紧张素 AT 受体:从结合位点到新的治疗靶点。
Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281.
10
Unveiling the Angiotensin-(1-7) Actions on the Urinary Bladder in Female Rats.揭示血管紧张素 -(1 - 7)对雌性大鼠膀胱的作用
Front Physiol. 2022 Jul 19;13:920636. doi: 10.3389/fphys.2022.920636. eCollection 2022.